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Abstract 
Purpose: 
 To evaluate the dosimetric accuracy of using deformed CT images for dose 
calculations, and to assess the feasibility of using these images during adaptive 
radiotherapy, for nasopharyngeal carcinoma (NPC) patients.   
 
Methods and Materials: 
 Thirty consecutive NPC patients who had undergone one re-plan in their 
radiotherapy treatments were selected.  The pre-treatment planning computed 
tomography (PCT) images were deformed to match the mid-treatment PCT images by 
deformable image registration.  The same volumetric modulated arc therapy plan was 
then calculated on the deformed PCT images.  The resulting dose distributions and dose 
volume histograms of the tumours and organs at risk (OARs) were compared to the 
original plan.  Five dose levels including D98%, D95%, D50%, D5%, and D2% were recorded 
for 9 NPC targets.  Four dose levels including Dmax, D10%, D50%, and Dmean were recorded 
for 15 OARs. 
 
Results: 
 The greatest percentage difference in observed dose for D98%, D95%, D50%, D5%, and 
D2% of the targets were 1.71%, 1.55%, 0.64%, 0.97%, and 1.13%, respectively.  The 
greatest percentage difference in observed dose for Dmax, D10%, D50%, and Dmean of the 
OARs were -26.51% (left optic nerve), -17.06% (left optic nerve), 56.70% (spinal cord), 
and 18.97% (spinal cord), respectively.  In addition, 29 out of 45 (64%) dosimetric 
endpoints of the targets showed statistically significant dose differences (P<0.05) between 
the original plan and the plan calculated on deformed images.  Forty-nine out of 60 (82%) 




 Dose calculations using deformed PCT images could result in significant dose 
uncertainties for NPC patients.  Further investigations are needed; meanwhile, it is 
suggested that a new PCT should be acquired in the case of re-planning at mid-course.  
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Introduction 
 Adaptive radiotherapy (ART) is a novel approach to correct for tumour and normal 
tissue variations during the course of treatment in order to maintain optimal target dose 
coverage and critical organs sparing.  This approach, however, will require additional 
computed tomography (CT) acquisitions which will increase workloads to the department 
and radiation dose to the patient.  The use of on-treatment cone-beam CT (CBCT) 
images for the purposes of re-planning can avoid extra CT acquisitions but may not be 
feasible for contour delineations and dose calculations due to their relatively poor image 
quality (1).  An ideal alternative would be the use of deformable image registration (DIR) 
to deform the planning CT (PCT) images to up-to-date CBCT images for dose calculations.   
 In this study, phase I (Ph I) PCT images were deformably registered to match the 
anatomy at phase II (Ph II) PCT images.  The rationale for not using CBCT images to 
perform the DIR was because the PCT-CBCT registration error could be a potential 
confounding variable.  A CT-CBCT registration is known as a quasi-intermodality case 
and Zhen et al. acknowledged the fact that there are uncertainties and errors existing in 
such DIR (2).    Although the underlying physical acquisition process for the CT and 
CBCT images is identical, the acquisition geometry is different which causes the CBCT to 
be corrupted by noise and artefacts (3).  The purpose of this study was to first evaluate 
the accuracy of using a CT-CT DIR (i.e. images of same modality) for dose calculations so 
that the result could then determine whether further study on the accuracy of using CT-
CBCT DIR for dose calculations is needed.  
 
Methods and Materials 
Patient population, image registration and treatment planning  
 Thirty consecutive nasopharyngeal carcinoma (NPC) patients who had completed 
their radiotherapy treatment to the nasopharyngeal region and the bilateral lymph nodes 
between 2010 and 2013 were retrospectively selected.  These patients must have 
received 2-phase radiotherapy treatment which included a mid-course PCT scan.  Any 
patients with CT images that had substantial artefacts such as numerous dental fillings, 
were excluded.    
 Helical PCTs were acquired using GE LightSpeed CT-simulator (GE Healthcare 
Technologies, Milwaukee, WI) at a 2.5-mm slice thickness.  The Ph II PCT scans were 
acquired between the 6th to 20th fraction of their treatment.  The number of days 
between Ph I and II PCT took place ranged from 25 to 63 days.  The Ph I and II image 
sets were deformably registered using a commercially available image registration 
software, MIM Maestro version 6.1.1 (MIM Software, Cleveland, OH).  The deformation 
engine applies a constrained intensity-based free-form deformable registration algorithm 
for CT-CT registration (4).  Image registrations were performed by the same investigator 
on a desktop computer with an Intel® Xeon® Processor W3550 at 3.07 GHz and a 12.0 
GB RAM.     
All dose calculations were performed using Eclipse v10.0 (Varian Medical Systems, 
Palo Alto, CA) with a calculation grid size of 0.25cm.  The calculation algorithm used was 
the Varian Anisotropic Analytical Algorithm model version 10.0.28. 
 
Workflow and methodology 
 The workflow and methodology are presented in Fig. 1.  Group I represents the 
normal route through which patients had undergone one replan during the course of their 
treatment.  Group II consists of the same patients as in group I and each patient's Ph II 
PCT was used as a reference image to which the Ph I PCT was registered.  Initially the 
CT images were co-registered using a rigid automatic match tool followed by some manual 
adjustments, mainly based on the nasopharyngeal region, in order to optimise the 
alignment to the primary tumour.  The deformable registration algorithm was then applied.  
The deformable alignment accuracy was tested based on a few manually identified 
landmarks.  The same 6 MV volumetric modulated arc therapy (VMAT) plan was applied 
and re-calculated on the deformed PCT images.  The treatment plans in group I and II for 
each patient were examined and compared dosimetrically. 
 
Plan comparison 
 Two dose volume histograms (DVHs) and isodose distributions were generated for 
each patient based on Ph II PCT and deformed PCT.  The dose tolerances for various 
OARs according to QUANTEC (5-10) were recorded and compared.  The treatment plan 
comparisons were done in three approaches: 
 
1)  Dose patterns in target volumes 
 There were 9 targets for each patient, namely NP-GTV, NP-CTV, NP-PTV, left/right 
LN-GTV, left/right LN-CTV and left/right LN-PTV.  The term “NP”, “LN”, “GTV”, “CTV”, and 
“PTV” represent the nasopharyngeal region or the primary tumour, the bilateral lymph 
nodes, the gross tumour volume, the clinical target volume, and the planning target 
volume, respectively.  Five dose levels, D98%, D95%, D50%, D5% and D2%, were recorded for 
each curve.  Percentage differences were calculated as 100 x ((B-A)/A), where B and A 
were the doses calculated based on deformed PCT and Ph II PCT, respectively.   
 
2)  Dose patterns in organs at risk (OARs) 
 Four dose levels, i.e. Dmax, D10%, D50% and Dmean were recorded for 15 OARs.  The 
15 OARs were brainstem, spinal cord, left/right eyes, left/right lens, left/right cochleas, 
optic chiasm, left/right optic nerves, oral cavity, larynx, and left/right parotid glands.  
Percentage differences were also calculated.     
 
 3)   DVHs and isodose distributions comparison 
 DVH comparison was performed between the original plan generated from Ph II 
PCT and the new plan generated from the deformed PCT.  Isodose distributions were 
also compared visually for individual patients.  
 
Statistical analysis 
 The statistical test used was the two-tailed paired t-test for the normally distributed 
data and the Wilcoxon signed-rank test for the non-normally distributed data.  A p-value of 
<0.05 was considered statistically significant.  GraphPad Prism version 5.0c for Mac OS 
X (GraphPad Software, San Diego, CA) was used for statistical analysis. The null 
hypothesis of the study was that there is no difference between the two groups. 
 
Results  
Target volumes dose comparison  
 Table 1 (top) summarises the dose statistics analysis of the pairwise comparison 
between the dose calculations using conventional PCT and deformed PCT images for the 
target volumes.  For simplicity, only the greatest percentage differences within the dose 
level for each nasopharyngeal target volume are shown.  Twenty nine out of 45 (64%) 
dosimetric endpoints of the target volumes showed statistically significant dose differences 
(p<0.05) between the two groups.  The greatest percentage difference in observed dose 
for D98%, D95%, D50%, D5%, and D2% of the target volumes were 1.71% (right LN-GTV), 
1.55% (right LN-GTV), 0.64% (right LN-GTV), 0.97% (NP-GTV), and 1.13% (NP-GTV and 
NP-CTV), respectively. 
 
OARs dose comparison  
 The dose statistics analysis of the pairwise comparison for spinal cord, left and right 
optic nerves is shown in table 1 (bottom) as the greatest differences were observed in 
these OARs.  As with the target volumes, only the greatest percentage differences within 
the dose level for the OARs are shown for simplicity.  Forty-nine out of 60 (82%) 
dosimetric endpoints of the OARs showed statistically significant dose differences (p<0.05) 
between the two groups.  The greatest percentage difference in observed dose for Dmax, 
D10%, D50%, and Dmean of the 15 OARs were -26.51% (left optic nerve), -17.06% (left optic 
nerve), 56.70% (spinal cord), and 18.97% (spinal cord), respectively.  For left optic nerve, 
the mean percentage difference in observed dose for Dmax and D10% were -4.57% 
(SD=5.77) and -3.52% (SD=3.66).  For spinal cord, the mean percentage difference in 
observed dose for D50% and Dmean were 3.70% (SD=10.56) and 2.79% (SD=5.00). 
 Table 2 shows the patient specific dose differences for spinal cord and left optic 
nerve.  Deviations of more than 5% can be observed in 3 OARs including brainstem, right 
cochlea and right eye.  Deviations of more than 10% can be observed in right lens.  
Deviations of more than 15% can be observed in 5 OARs including spinal cord, left lens, 
optic chiasm, left optic nerve and right optic nerve.          
 
Example of individual results 
 Figures 2A, 3A and 4A show the registration result and dosimetric comparison of a 
NPC patient with Stage III T2bN2M0 undifferentiated carcinoma.  Good agreement was 
found between the Ph II PCT (solid line) and the deformed PCT (dotted line) based dose 
calculations for the target volumes and OARs (Fig. 2A).  Only minimal anatomical 
changes were observed on the Ph II PCT as compared with Ph I PCT (Fig. 3A).  The 
overall isodose distributions on the Ph II PCT scan (left) and the deformed PCT scan 
(right) were quite comparable (Fig. 4A). 
 Figures 2B, 3B, and 4B show the results of another NPC patient with Stage III 
T1N2M0 undifferentiated carcinoma.  There were dose discrepancies between the Ph II 
PCT (solid line) and deformed PCT (dotted line) calculations for OARs including left lens 
(yellow), left optic nerve (light blue), right optic nerve (dark purple), and spinal cord (cyan) 
(Fig. 2B).  The largest discrepancy was observed in spinal cord in particular.  Rigid 
registration result shows a relatively better alignment in the nasopharyngeal region at the 
level of base of skull and C1 vertebra, however, a significant mismatch was seen in the 
neck region starting from C5 vertebra and below (Fig. 3B).  Despite the mismatch at the 
neck region, isodose distributions in the level of C5 vertebra were quite comparable (Fig. 
4B).           
 Figures 2C, 3C, and 4C show the results of a patient with a primary tumour that was 
in close proximity to the optic chiasm and the optic nerves.  The rigid registration result 
was excellent (Fig. 3C), however, there was a significant dosimetric discrepancy between 
the DVHs for left (light blue) and right (dark purple) optic nerves (Fig. 2C).  In addition, a 
difference in isodose distributions especially in the air cavity-soft tissue interface around 
the paranasal sinuses can be observed (Fig. 4C).  
 
Discussion 
 Re-plans are common encounters in radiotherapy of NPC patients due to tumour or 
normal tissue changes during the course of treatment.  Acquiring a new PCT for re-
planning causes extra radiation exposure to the patient and increases workload to the 
radiation department.  One method that is being widely investigated to replace the need 
of acquiring new PCT is to use the on-treatment kV CBCT images for dose calculation (1, 
11-14).   
 Yang et al. and Yadav et al. both studied the accuracy of CBCT-based dose 
calculation with the intention of determining the feasibility of using these images for the 
purpose of dosimetric checks (1, 13).  Their results showed that it is acceptable to use 
CBCT images for dose calculation.  Two studies, one by Ding et al. and the other by Hu 
et al., further investigated the feasibility of using CBCT for treatment planning in ART (11, 
14).  Their results were also in good agreement that CBCT-based treatment plans were 
dosimetrically comparable to CT-based treatment plans.  Although the results sounded 
promising, the authors of both studies suggested that CBCT images should only be used 
for dosimetric validation at the moment.  An additional PCT will still be necessary to 
perform re-planning because of the suboptimal image quality of CBCT.  The inferior 
image quality of CBCT due to scattered radiation may hinder the oncologist's ability to 
accurately delineate the tumour and critical organs. In addition, the slow gantry rotation 
speed of the linac makes the CBCT more prone to motion artefacts (1).  Another limitation 
of CBCT is the limited field of view (especially in the longitudinal direction) which renders 
the resultant images non-usable for treatment planning (14).  Given these limitations, our 
study explored the possibility of using a deformed CT image for dose calculations in order 
that up-to-date tumour and normal tissue information can be used for treatment planning 
without acquiring a new PCT while maintaining acceptable image quality for accurate 
delineation.     
 The results of this study, however, demonstrated that treatment planning with 
deformed PCT images may lead to dosimetric uncertainties.  Target dose comparison 
shows better agreement, when compared to OARs dose comparison, in dosimetric 
difference between conventional PCT-based treatment plans and deformed PCT-based 
treatment plans.  Although statistical significance was found in 64% of the target volume 
dosimetric endpoints, the greatest percentage difference was only 1.71% which may not 
necessarily be clinically significant.  The DVHs for all the target volumes nearly overlay 
one another showing dosimetric consistency between the 2 CT scans (Fig. 2).   
 Larger dose discrepancies, on the other hand, were seen in the OARs especially in 
critical structures such as the lens, optic chiasm, optic nerves and spinal cord.  Eighty two 
percent of the dosimetric endpoints showed statistically significant difference.  In addition, 
dose differences that were greater than +5%, +10%, +15%, and up to 56.7%, can be 
observed in the OARs dose comparisons.  Such large dose deviations could translate into 
significant clinical outcomes which adversely affect the intention of ART.     
 Individual examples shown above suggested that the large dose deviation found 
may be due to residual registration error.  Patient one (Fig. 2A, 3A, 4A) remained 
anatomically consistent throughout the treatment as an excellent rigid registration result 
was obtained, even though the time frame between Ph I and Ph II PCT was 25 days apart.  
The resulting DVHs and isodose distributions both demonstrated excellent agreement 
between the conventional PCT-based and deformed PCT-based treatment plans.  Patient 
two (Fig. 2B, 3B, 4B) experienced a change in anatomical structures between the Ph I and 
II PCT which could be caused by setup reproducibility error or a change in patient's body 
weight.  The decision to align the CT images based on the base of skull, nasopharyngeal 
region and C1-2 vertebra was made because it was believed that priority should be given 
to maintaining a good alignment around the primary tumour area, hence a resulting 
mismatch of the C5 vertebra and the region below was inevitable.  The suboptimal result 
of the rigid registration may lead to a residual error in deformable registration.  The 
resulting large dose deviation seen in the DVHs of the spinal cord subsequently confirmed 
the speculation of residual registration error.  Despite the large dose deviation on the 
DVHs, it was difficult to identify the difference in isodose distribution (Fig. 4A).  Patient 
three (Fig. 2C, 3C, 4C) showed large dose discrepancies for the optic nerves between 
conventional CT-based and deformed CT-based treatment plans.  Accuracy in dose 
calculation is particularly essential in this patient to ensure the dose received by the optic 
nerves stayed within tolerance.  The isodose distribution demonstrated a significant 
difference especially in the air-tissue interface in the paranasal sinus region (Fig. 4C).  
Despite a satisfactory result in the alignment of the bony anatomy (Fig. 3C), the dose 
discrepancies shown in this case suggested that deformable registration result may be 
unreliable for structures that are small with lack of contrast with the background.  This 
was further confirmed by the results in which large dose deviations were generally 
observed in smaller OARs such as the lens, eyes, optic nerves, optic chiasm and 
cochleas.  When the dose to the OARs are reaching tolerance limits such as in cases 
when the tumour is extremely close to structures like brainstem or optic nerves, or in cases 
when the patient is having another course of radiation treatment due to local recurrence, 
any deviations in dose calculation accuracy may lead to serious consequences.  The 
results in this study, therefore, suggested that the deformed image-based dose calculation 
will create dose uncertainties that may not be suitable for re-plan in NPC patients.          
    As mentioned earlier, the PCT-CBCT registration may introduce image noise and 
produce registration results that were less accurate.  The results presented here 
suggested that the use of CT-CT DIR failed to provide accurate dose calculations which 
further suggest that a PCT-CBCT DIR may produce equal or even less accurate results.  
One limitation of this study was that the assessment of DIR accuracy was difficult.  
Although inter-observer variation was avoided by performing all registration procedures by 
a single investigator, the accuracy of the deformable registration was still difficult to 
quantify.  One approach used in this study was manually identifying several critical 
anatomical landmarks for verification by visual inspection, however, it may not be sufficient 
for generalising the accuracy results to the entire region of interest.  In addition, when 
there is a significant change in anatomy between the 2 image sets as encountered in 
patient two, how the rigid registration was performed became a subjective decision by the 
individual investigator.  No consensus guidelines exist on whether matching to several 
important structures is more desirable than matching to the overall trend.  Kashani et al. 
found that different implementations, different users, or different parameter settings of the 
same type of registration can result in different accuracy (15).  Accomplishing deformable 
registration with accuracy is particularly essential in this study because precise ART 
cannot be delivered if there are registration errors which would defeat the purpose of the 
re-plan.   
 In this study, a commercially available image registration software was used which 
utilises a constrained intensity-based free-form deformable registration algorithm for CT-
CT registration.  A more robust DIR algorithm is desirable in order to increase the 
accuracy.  Several techniques have been used to accomplish accurate DIR (2, 16-17).  
Castadot et al. compared 12 DIR strategies for the treatment of head and neck tumours 
(16).  Their results show that the use of the Demons' algorithm, implemented in multi-
resolution, followed by the level-set algorithm and using images that have undergone 
preliminary edge-preserving denoising, is a good registration strategy for head and neck 
ART.  The full explanation of the technical details of this method can be found in the 
original paper.  Zhen et al. also suggested that the use of Demons algorithm for CT-CT 
registration and a modified demons algorithm known as Deformation with Intensity 
Simultaneously Corrected (DISC) for CT-CBCT registration can produce a robust result 
(2).    
 
Conclusions 
 Future investigation using a more robust DIR algorithm may lead to more accurate 
dose calculation results.  It is important to evaluate the dosimetric accuracy of using 
deformed image for dose calculations because it could potentially replace the need of re-
plan CT, and as a result, reduce the radiation exposure of the patient and the workload of 
the department.   
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Fig. 1.  Workflow diagram illustrating different steps to obtain dose and volume 
parameters. 
 
Table 1.  Statistical analysis of the dosimetry differences between the treatment plans 
based on the deformed PCT images and the original PCT images for the nasopharyngeal 
target volumes (top) and OARs (bottom). 
 
Table 2.  Patient specific dose differences for spinal cord and left optic nerve.  The “-”, 
“+” or “0” sign indicates that the dose calculated with the deformed PCT image is smaller 
than, larger than, or no differences with the dose calculated with the original PCT image, 
respectively.     difference within +5%;     difference is greater than +5%;    
difference is greater than +10%;    difference is greater than +15%. 
 
Fig. 2A-C.  DVHs comparison of target volumes and OARs for the treatment plans 
generated by the original PCT (solid line) and deformed PCT (dotted line) for (A) patient 
one; (B) patient two; and (C) patient three. 
 
Fig. 3A-C.  Rigid and deformable registration results for the three corresponding patients 
shown in fig. 2.  The top panel shows the orthogonal views of the rigid registration with 
checkerboard overlay of the 2 CT scans and the bottom panel shows the orthogonal views 
of the CT image after deformable registration. 
 
Fig. 4A-C.  Isodose distributions comparison of CT-based (left) and deformed CT-based 
(right) VMAT plans for the three corresponding patients shown in fig. 2 and 3.  
